PaperlayerView exact revision on arXiv

Source-linked AI summary

AI Consilium: a Benchmark of LLM Clinical Multidisciplinary Second Opinions

Alexey A. Bokov, Ivan I. Panin, Nikolay B. Nechaev, Mikhail Yu. Valkov, Valeria Yu. Chernina, Natalia Gombolevskaya, Ayyaz Hussain, Vladimir M. Agafonov, Victor A. Gombolevskiy, Aleksandr V. Nesterov, Iaroslav R. Bespalov, Ivan V. Oseledets, Dmitry V. Dylov

arXiv:2610.22298v1cs.CLcs.AI

TL;DR

Diagnostic accuracy alone does not capture whether a clinical second opinion is grounded, coherent, actionable, and safe. The paper benchmarks role-specific opinions and multidisciplinary synthesis across response structures and models; structured and free-form pipelines show different deliberation patterns.

  • Problem

    Diagnostic accuracy alone does not establish the factual grounding, reasoning coherence, planning quality, uncertainty handling, or safety needed in a clinical second opinion.

    Source: §1 · p. 2

  • Method

    The benchmark evaluates standalone role-specific opinions and interactive consilium reports on 300 NEJM-MedQA cases, using physician ratings and a calibrated LLM Judge.

    Source: §1 · p. 3

  • Results

    Structured and free-form pipelines averaged 1.89 and 1.76 review rounds, respectively, and reached consensus in 97.3% and 98.4% of instances.

    Source: §4.2 · p. 14

  • Takeaways & Limitations

    The benchmark separates evaluation of standalone opinions and final consilium reports while examining model choice, response structure, synthesis, and inference requirements.

    Source: §1 · p. 3

    Prompted specialist roles are not validated medical specialization, so role labels alone do not establish stable domain expertise.

    Source: §2.4 · p. 5

Abstract

from arXiv · show

Large language models (LLMs) can generate differential diagnoses for complex cases, but a useful second opinion must also be factually grounded, clinically coherent, actionable, and safe. We developed a multidimensional benchmark using 300 diagnostically resolved NEJM--MedQA cases: 110 for physician reference ratings and Judge calibration and 190 for held-out evaluation. Eight single-model pipelines generated independent role-specific opinions and interactive-consilium reports under free-form and structured clinical-reasoning conditions. A physician-calibrated LLM Judge evaluated 3,040 final reports and the corresponding structured primary-role outputs. Model identity separated report quality more strongly than response format. Structured final reports had higher overall mean scores in seven of eight model pipelines, with their clearest advantage in management (2.740 vs. 2.436). Compared with the structured pre-consilium primary-role opinion, the complete structured synthesis had higher pooled scores across all five shared criteria, with the largest increases in problem prioritization, factual grounding, and reasoning coherence. GPT-5.6-Sol led every evaluated component and reached consensus in the fewest review rounds. These findings show that the benchmark can distinguish model capability, the contribution of multidisciplinary synthesis, criterion-specific effects of response structure, deliberation dynamics, and inference requirements within one common-case evaluation.

1 Introduction

A high-quality clinical second opinion requires more than diagnostic accuracy: it must also support coherent, grounded, actionable, and safe decisions. The study benchmarks role-specific opinions and consilium reports while separately examining model choice, response structure, synthesis, deliberation, and evaluation.

1 Introduction

  • Diagnostic accuracy alone does not establish a high-quality second opinion, which also depends on factual grounding, coherent reasoning, planning, uncertainty, and safety.Repeat expert review can change treatment as well as diagnosis, and it may not be possible to determine objectively which opinion was more accurate.Source: §1 · p. 2
  • The benchmark uses 300 NEJM-MedQA cases, with 110 for physician annotation and Judge calibration and 190 held out for evaluation.It compares standalone role-specific opinions with a later interactive consilium synthesis on the same cases.Source: §1 · p. 3
  • Role-specific opinions and final consilium reports are evaluated as distinct clinical products on the same cases.Source: §1 · p. 3
  • The evaluation framework separates factual grounding, prioritization, data use, reasoning coherence, differential diagnosis, conclusion quality, management, and safety.Source: §1 · p. 3
  • The benchmark compares model choice, response structure, synthesis stage, deliberation dynamics, and inference requirements.Source: §1 · p. 3
  • A physician-developed rubric and criterion-wise calibration of an LLM Judge support scalable evaluation of open-ended clinical second opinions.Source: §1 · p. 3

2 Related Work

Prior work motivates evaluating second opinions across diagnosis and management, while distinguishing the effects of response structure, multi-agent interaction, inference cost, and automated judging. The study positions its contribution as a same-case decomposition of these stages and design choices.

2.1 Second Opinions and Multidisciplinary Teams

  • Second opinions and multidisciplinary discussions can change diagnosis or management, but consensus or discussion alone does not guarantee correctness.Their effects vary with information completeness, workflow, and team composition; useful evaluation tracks what deliberation preserves, revises, or loses.Source: §2.1 · p. 3

2.2 LLMs on Complex Clinical Cases: From Diagnosis to the Full Decision Trajectory

  • Strong diagnostic performance does not ensure adequate quality across information gathering, treatment, risk, uncertainty, and safety.Prior work therefore motivates assessing the broader clinical decision trajectory rather than diagnosis alone.Source: §2.2 · pp. 3–4

2.3 Structured Clinical Reasoning, Verification, and Test-Time Inference

  • Structured reasoning and verification have produced model- and task-dependent results, while added generations or critique can also affect performance.Comparisons should account for inference budgets rather than attributing gains automatically to structure or council interaction.Source: §2.3 · p. 4

2.4 Medical Multi-Agent Systems and the Computational Confounding Problem

  • Medical multi-agent systems demonstrate feasibility, but their gains can bundle extra generations, aggregation, prompting, retrieval, and interaction.Inference cost and compute-matched controls are therefore important, and prompted role labels do not establish validated medical specialization.Source: §2.4 · pp. 4–5

2.5 Human–AI Collaboration, Automation Bias, and Clinical Safety

  • Human–AI collaboration outcomes vary, and plausible or erroneous AI advice may influence clinicians without ensuring better decisions.Persuasiveness and clinical correctness should be evaluated separately; clinician outcomes remain outside this benchmark’s scope.Source: §2.5 · p. 5

2.6 LLM-as-a-Judge and Physician Expert Evaluation

  • LLM judges show task- and criterion-dependent agreement with physicians, motivating physician reference ratings and validation for each criterion.Agreement on one dimension should not be assumed to generalize to treatment, safety, or uncertainty.Source: §2.6 · p. 5

2.7 Positioning of the Present Study

  • The study addresses a gap by evaluating standalone role opinions and subsequent synthesis on the same cases while varying design choices and validating an LLM judge criterion by criterion.Its contribution is empirical decomposition, not an assumption that multidisciplinary deliberation is intrinsically superior.Source: §2.7 · p. 6

3 Methods

The study evaluates independent role-specific opinions and interactive multidisciplinary reports on diagnostically resolved NEJM cases, using physician ratings to calibrate a Judge for held-out evaluation. Its methods specify the case split, generation conditions, evaluation criteria, and criterion-specific Judge calibration.

3.2 NEJM Clinical Case Dataset, Selection Rationale, and Prespecified Split

  • The 300-case NEJM–MedQA corpus was split into 110 cases for physician annotation and Judge calibration and 190 held-out evaluation cases.The cases were DOI-unique and published in 2015–2023; the held-out cases were not used for annotation or calibration.Source: §3.2 · p. 7

3.3 Role Assignment And Independent Role-Specific Second Opinions

  • Cases received one to five selected clinical roles, whose independent opinions were fixed before a consilium synthesized and iteratively reviewed them.The cycle stopped at consensus, no substantive change, a repeated report state, or five rounds; the final opinion retained unresolved disagreement and uncertainty.Source: §3.3 · p. 7, §3.4 · pp. 7–8
  • The structured response schema required clinical information, syndromes and mechanisms, differential reasoning, diagnostic and treatment tactics, and a final opinion.Because the structured condition also provided more detailed reasoning instructions, comparisons measured the combined prompting approach, not response format alone.Source: §3.3 · p. 7

3.5 Construction of the Physician-Annotation Corpus

  • The physician-annotation corpus used four eligible models in a 3+1 workflow, with GLM-5.2 consolidating three workers’ outputs and conducting the interactive consilium.Both free-form and structured pipelines processed the 110 cases using the same finalized role panel.Source: §3.5 · p. 8

3.6 Single-Model Evaluation

  • Eight single-model configurations generated role-specific opinions and consilium reports under free-form and structured conditions on the same ordered held-out cases.Each model performed role assignment, opinion generation, review, revision, and finalization; each pipeline used at most five review rounds.Source: §3.1 · p. 6, §3.6 · p. 8

3.7 Evaluation Criteria

  • The eight response-quality criteria covered grounding, prioritization, data use, reasoning, diagnosis, conclusion, management, and safety, scored on a 0–3 scale.Physicians applied the criteria separately to reasoning, role-specific opinions, and final consilium reports; fabricated clinically significant facts triggered a zero for factual accuracy and capped related criteria.Source: §3.7 · pp. 8–9, §3.8 · p. 9

3.8 Physician Reference Evaluation

  • Six physicians provided blinded reference ratings, while GPT-OSS-120B served as a physician-calibrated Judge scoring one target component per call.The Judge used criterion definitions, score anchors, applicability rules, and optional instructions; structurally inapplicable fields, not-evaluable outcomes, and failures were not converted to zero.Source: §3.8 · p. 9, §3.9 · pp. 9–10, §3.11 · p. 11

3.10 Exploratory Analysis of Completion Rounds and Judge Scores

  • The study descriptively examined Judge scores by review-round count and optimized separate prompts for criteria 1–9 against physician ratings.Calibration used training observations and repeat seeds; the authors treated MAE as an error summary rather than a complete validity measure.Source: §3.10 · p. 10, §3.11 · p. 10

4 Results

Across the held-out benchmark, model identity separated final-report quality more strongly than response format, while structured reporting showed a broad but modest advantage. Complete multidisciplinary synthesis scored higher than structured primary-role opinions across every shared criterion, and review usually converged within two rounds.

4.1 Evaluation Cases Composition

  • 1,260 of 1,520 panels (82.9%) selected five roles, the assignment ceiling, limiting variation for assessing whether panel size adapted to cases.The 7,271 assignments used 696 exact role labels; infectious disease, radiology, and neurology were the most frequent harmonized categories, while neurology and infectious disease were the most frequent primary roles.Source: §4.1 · p. 12

4.2 Consilium Dynamics

  • 97.8% of 3,040 review instances reached unanimous report consensus; 84.7% did so by round 2, including 96.4% of initially disputed instances.GPT-5.6-Sol accepted most reports at the first review and required the fewest rounds, while aggregate structured pipelines averaged 1.89 rounds versus 1.76 for free-form.Source: §4.2 · p. 14, Figure 3 · p. 15

a Complete-pipeline token use by model and response format

  • A complete structured pipeline averaged 133.3 thousand provider-reported tokens per case, compared with 106.9 thousand for free-form.The structured path used 26.5 thousand additional tokens; these descriptive token units are tokenizer-specific and not matched compute budgets.Source: §4.2 · p. 14, Figure 5 · p. 17

b Token use by pipeline stage and response format

  • Figure 5 breaks mean token use per case down by pipeline stage and response format, averaged across the eight-model evaluation.The shared role-assignment token value is repeated to show a standalone path's resource requirement but counted once in the experiment-wide total.Source: Figure 5 · p. 17

4.3 Physician Ratings and Judge Calibration

  • Criterion-local Judge guidance reduced macro-mean validation MAE to 0.7798, a 9.3% improvement over no additional guidance.The largest validation reductions were factual grounding (1.2222 to 0.6296) and management (0.8889 to 0.5000).Source: §4.3 · p. 18, Table 5 · p. 18

4.4 Held-Out Benchmark Performance

  • Structured final reports had higher overall means than free-form reports in seven of eight model pipelines; management was 2.740 versus 2.436, a 0.304-point gain.The complete multidisciplinary synthesis had higher pooled Judge means for every criterion shared with isolated primary-role components.Source: §4.4 · pp. 19–20

4.5 Distribution of Judge Scores Across Cases and Criteria

  • Problem prioritization, reasoning coherence, and differential diagnosis were strongest, while clinical-conclusion quality and safety retained the most measured variation.Maximum scores occurred in 81.5% for prioritization, 90.4% for coherence, and 80.9% for differential diagnosis; 62.8% of numeric conclusion-quality scores were 0 or 1.Source: §4.5 · pp. 21–22, Figure 6 · p. 21, Figure 7 · p. 22

4.6 Judge Scores and Consilium Completion Rounds

  • Longer review trajectories showed no quality advantage: mean final-report scores were 2.525 after one round, 2.419 after two, and 2.438 after three or more.The comparisons were descriptive and support prospective evaluation of early stopping, but do not estimate the effect of ending an ongoing review early.Source: §4.6 · p. 23, Table 9 · p. 23, Figure 8 · p. 23

5 Discussion

Model identity differentiated report quality more strongly than response format, while the full structured synthesis scored higher than the primary-role opinion on every shared criterion. The benchmark also separates clinical quality dimensions, synthesis stages, and deliberation process.

5.1 Principal Findings

  • GPT-5.6-Sol led every evaluated component; structured reports had higher overall means in seven of eight pipelines, and full synthesis improved all five shared criteria.The structured-report advantage was driven primarily by a 0.304-point improvement in management; eventual consensus occurred in 97.8% of reports, but longer review trajectories had no final-report score advantage.Source: §5.1 · p. 23
  • The structured final synthesis had higher pooled means than the primary-role opinion on every shared criterion, with the largest gains in prioritization, grounding, and coherence.This comparison reflects aggregation, review, revision, and finalization together, not an isolated effect of discussion.Source: §5.1 · pp. 23–24
  • Structured prompting’s clearest advantage was management, which improved in seven of eight models and drove higher overall means despite some smaller criterion differences favoring free-form reports.Smaller gains in prioritization and grounding also indicate a more organized, actionable plan, rather than uniform improvement across criteria.Source: §5.1 · p. 24

5.2 Value of the Benchmark

  • The benchmark scores eight dimensions of clinical response quality and compares primary-role opinions with final consilium reports on the same cases.Its matched free-form and structured panels distinguish response-format effects from model identity, while evaluating which clinical dimensions change across synthesis stages.Source: §5.2 · p. 24
  • Recording dissent, consensus, review rounds, finalization, and token use alongside quality scores distinguishes procedural agreement from output quality.This captures configurations such as GPT-5.6-Sol, which combined strong clinical scores with rapid convergence.Source: §5.2 · p. 24

6 Conclusion

The benchmark evaluates LLM-generated second opinions across multiple clinical-quality dimensions and compares model pipelines and synthesis stages. It found higher ratings for structured synthesis than primary-role opinions across shared criteria, while prospective studies are still needed to assess effects on clinical practice and patient care.

6 Conclusion

  • Across 190 held-out cases, structured final consilium reports scored higher than pre-consilium primary-role opinions on every shared criterion, while structured reports had higher overall means in seven of eight models.GPT-5.6-Sol led every evaluated component and reached consensus in the fewest review rounds.Source: §6 · p. 24
  • The benchmark evaluates factual grounding, prioritization, data use, reasoning, differential diagnosis, conclusions, management, and safety, capturing differences that diagnostic accuracy alone would miss.Structured reporting increased inference requirements, and additional review rounds were not associated with higher final-report scores.Source: §6 · p. 24
  • Prospective studies remain necessary to establish effects on clinician decisions and patient care.Source: §6 · p. 24

7 Limitations

The evaluation is bounded by the unusual published cases, simulated specialty roles, and bundled synthesis and prompting conditions. Its Judge and rubric also have calibration and validation constraints, and the study evaluates reports rather than clinical outcomes.

7 Limitations

  • NEJM Case Records overrepresent unusual, difficult cases and do not reproduce routine prevalence, documentation, time pressure, or longitudinal uncertainty.Their published diagnoses are useful targets but not exhaustive ground truth for management; possible training-data exposure also prevents separating memorization from de novo reasoning.Source: §7 · p. 24
  • Prompted roles are simulated perspectives rather than independently validated specialists, and they may share correlated errors.Source: §7 · p. 25
  • The consilium used more calls, context, and tokens than a standalone opinion without compute matching to isolate sampling, review, and interaction.The structured condition also changed instructions, output length, and downstream context, so observed differences cannot be attributed to format alone.Source: §7 · p. 25
  • Judge scores may share knowledge, style preferences, or failure modes with evaluated models, and the rubric was not externally validated.Calibration used a limited physician-rated sample with criterion-specific error; prompt semantic drift and exclusion of non-evaluable scores could also affect results, while clinical effects were not evaluated.Source: §7 · p. 25

A Expanded Judge Score Summaries

The appendix documents how Judge scores and coverage are summarized, then specifies the interactive-consilium algorithm for producing and reviewing a final report.

B Formal Interactive Consilium Algorithm

  • The algorithm selects one to five roles, including a primary role, and independently generates and freezes each role-specific opinion before synthesis.The same clinical case is supplied to each role-specific opinion generator.Source: B Formal Interactive Consilium Algorithm · p. 33
  • All roles review the same current report in each round; unanimous yes votes retain that report and stop review with consensus.The algorithm allows up to five review rounds.Source: B Formal Interactive Consilium Algorithm · p. 33
  • When reviews do not yield consensus, a moderator records substantive changes and objection dispositions; the process stops for no change, a repeated report, or the round limit.The controller returns the final clinical opinion, completed-round count, consensus indicator, and stop reason.Source: B Formal Interactive Consilium Algorithm · p. 33

C Complete Free-Form Interactive-Consilium Report

The reproduced free-form report shows how specialists can agree on reassuring imaging yet differ on diagnosis and whether to sample tissue. Its final synthesis leaves the etiology and management unresolved pending missing test results.

C Complete Free-Form Interactive-Consilium Report

  • The appendix reproduces the complete free-form interactive-consilium report for an eight-year-old boy with an enlarging right breast mass; consensus was reached after one review round.The report is presented without omitted or edited text, though reformatted for presentation.Source: C Complete Free-Form… · p. 34

C.3.2 Concilium Participants

  • The report assigns endocrinology, radiology, surgery, and pathology complementary roles in evaluating hormones, characterizing imaging, managing the mass, and establishing histology.Its overall rationale calls for endocrine-led evaluation, imaging, tissue diagnosis, and surgical management to establish etiology and direct therapy.Source: §C.3.2 · p. 35, §C.3.3 · p. 35

C.4.1 Pathology

  • The pathology opinion recommends tissue diagnosis for a progressively enlarging, discrete unilateral mass because imaging alone could miss rare entities such as secretory carcinoma or juvenile fibroadenoma.It prefers excisional biopsy to assess architecture, with core needle biopsy as an alternative; fine-needle aspiration is generally inadequate for this differential.Source: §C.4.1 · p. 35

C.4.2 Pediatric Endocrinology

  • Endocrinology favors asymmetric benign gynecomastia with isolated premature adrenarche, citing fine lightly pigmented hair, prepubertal testes, and bone age matching chronological age.If laboratory and imaging evaluation is reassuring, its proposed plan is expectant management with follow-up every 3 to 6 months.Source: §C.4.2 · p. 36

C.4.3 Pediatric Surgery

  • All specialists consider the ultrasound reassuring for a benign process, but disagree about whether the discrete, enlarging mass represents gynecomastia or a benign neoplasm.Endocrinology and radiology favor observation if the endocrine evaluation is reassuring; surgery and pathology favor tissue diagnosis if no systemic cause is found.Source: §C.4.3 · p. 37, §C.5.1 · p. 38
  • Surgery considers the persistent, enlarging discrete mass less typical of physiologic gynecomastia and recommends excision for diagnosis and treatment if endocrine evaluation finds no systemic cause.A circumareolar or subareolar approach is preferred for cosmetic outcomes.Source: §C.4.3 · p. 37

C.4.4 Radiology

  • Radiology reads the sonographic morphology as overwhelmingly benign and considers asymmetric gynecomastia the primary diagnosis, while retaining juvenile fibroadenoma as a secondary possibility.It recommends short-interval ultrasound follow-up if the endocrine workup is benign and the mass remains stable.Source: §C.4.4 · pp. 37–38

C.5.1 Final Opinion

  • The final report leaves gynecomastia versus benign fibroepithelial neoplasm, and tissue sampling versus observation, unresolved; specialists agree that pending endocrine results and chest imaging must be reviewed first.The report notes that laboratory results, chest imaging, and details of diagnostic procedures are absent from the case input.Source: §C.5.1 · pp. 38–39

D Complete Structured Interactive-Consilium Report

The appendix reproduces the structured interactive-consilium report for the same case as the free-form report, allowing direct comparison of response formats. Its controller metadata records consensus after one review round.

D Complete Structured Interactive-Consilium Report

  • The appendix reproduces the complete structured report for the same case as the free-form report, enabling direct comparison between the two response formats.The report is reformatted for presentation without text being omitted or edited.Source: D Complete Structured… · p. 40
  • The structured report concerns the eight-year-old boy with an enlarging right breast mass, and its controller metadata records consensus after one review round.Source: D Complete Structured… · p. 40

D.2 Case Description

The case describes an eight-year-old boy with a persistent, recently enlarging right breast mass and early pubertal signs. The report assigns four specialties complementary roles in evaluating and managing the presentation.

D.2 Case Description

  • An eight-year-old boy had an 18-month history of a right breast mass that had recently enlarged, with fine pubic hair also reported.Examination found a mobile mass under the right areola; ultrasound showed a well-circumscribed, hypovascular retroareolar mass without typical aggressive features.Source: §D.2 · p. 40

D.3.2 Concilium Participants

  • The proposed concilium includes pediatric endocrinology, radiology, pediatric surgery, and pathology, addressing hormonal causes, imaging, surgical management, and histologic diagnosis.Source: §D.3.2 · p. 41

D.3.3 Overall Rationale

  • The stated rationale is an endocrine-led evaluation with imaging characterization, tissue diagnosis, and surgical management to establish etiology and direct therapy.Source: §D.3.3 · p. 41

D.4.1 Pathology

The mass most likely represents prepubertal gynecomastia or fibroadenoma, but rare malignancy cannot be excluded by imaging alone. Tissue diagnosis is the priority for resolving the differential.

D.4.1 Pathology

  • The unilateral mass occurs alongside fine pubic and axillary hair, prepubertal testes, and normal bone age, while endocrine laboratory values remain unavailable.The missing hormone results and pending histopathology are key gaps for distinguishing a hormonally driven benign process from a neoplasm.Source: §D.4.1 · pp. 41–42
  • The well-circumscribed mass lacks malignant imaging features, but secretory carcinoma remains a rare possibility requiring histopathologic exclusion.Clinical and imaging benignity cannot guarantee benign histology in this age group.Source: §D.4.1 · p. 42
  • Tissue diagnosis is mandatory; ultrasound-guided core needle biopsy is the initial procedure, with excisional biopsy if sampling is nondiagnostic or atypical.Radiologic-pathologic discordance also warrants repeat biopsy or excision.Source: §D.4.1 · p. 42
  • Management depends on histology: benign lesions may be observed or locally excised, whereas secretory carcinoma or sarcoma requires oncologic planning with staging and margin control.The proposed evaluation also includes reviewing the hormone panel and assessing radiologic-pathologic concordance.Source: §D.4.1 · p. 42
  • The leading considerations are prepubertal gynecomastia and fibroadenoma, with the latter supported by classic smooth, mobile sonographic morphology but rare in prepubertal males.Histology distinguishes benign ductal proliferation from a biphasic neoplasm.Source: §D.4.1 · pp. 41–42

D.4.2 Pediatric Endocrinology

The presentation combines unilateral breast enlargement with premature adrenarche but no evidence of central puberty. Review of pending endocrine results and exclusion of peripheral hormone sources guide diagnosis and management.

D.4.2 Pediatric Endocrinology

  • The 8-year-old has an enlarging right breast mass, fine pubic and axillary hair, prepubertal testes, and normal bone age, while laboratory values are unavailable.Ultrasound shows a benign-appearing solid mass; chest imaging and diagnostic-procedure results are also unreported.Source: §D.4.2 · pp. 42–43
  • The differential includes premature-adrenarche-associated gynecomastia, peripheral estrogen excess, hCG-secreting tumor, congenital adrenal hyperplasia, and malignancy.Hormone results and imaging can help distinguish these alternatives; biopsy is identified as confirmation for a malignant breast lesion.Source: §D.4.2 · p. 43
  • Review the pending hormone panel and diagnostic results, and perform testicular ultrasound; if the workup is normal, observation with 3–6-month follow-up is proposed.Avoid empirical anti-estrogen or aromatase-inhibitor therapy until a hormonally active tumor is excluded; consider biopsy or surgical referral if the mass persists, enlarges, or causes significant distress.Source: §D.4.2 · p. 43
  • The leading hypothesis is idiopathic or early physiologic gynecomastia, but peripheral estrogen excess and hCG-secreting tumors must be excluded.Prepubertal testes and normal bone age argue against central precocious puberty.Source: §D.4.2 · p. 43

D.4.3 Pediatric Surgery

The persistent, enlarging unilateral mass is considered most likely gynecomastia or a benign fibroepithelial lesion, but malignancy and hormonally active tumors require exclusion. The proposed surgical plan depends on reviewing pending tests before excisional biopsy.

D.4.3 Pediatric Surgery

  • The discrete mass has persisted for 18 months and enlarged, despite benign-appearing ultrasound and no skin fixation; tissue sampling is proposed because the lesion exceeds simple observation.The concurrent early adrenarche does not explain the unilateral mass in the absence of central puberty or advanced bone age.Source: §D.4.3 · p. 44
  • The proposed operation is complete excision through a periareolar approach, preserving the nipple-areolar complex and sending an oriented specimen for definitive histology.Endocrinology, radiology, and pathology provide preoperative results, imaging support, and specimen evaluation; oncology is involved if malignancy is identified.Source: §D.4.3 · p. 45
  • The leading possibilities are persistent idiopathic gynecomastia or a benign fibroepithelial lesion, while malignancy and hormonally active tumors must be excluded first.The differential weighs the benign-appearing imaging against persistence, enlargement, and a firm discrete mass.Source: §D.4.3 · pp. 44–45
  • The proposed plan is a right periareolar excisional biopsy after review of hormone and tumor-marker results and chest imaging, with histology determining subsequent management.The procedure is intended as both a diagnostic and therapeutic maneuver for the persistent, enlarging mass.Source: §D.4.3 · pp. 45–46
  • Any abnormal endocrine result would redirect the plan from straightforward excision toward endocrine or oncologic work-up.The missing laboratory values and chest-imaging report are decision-relevant gaps before surgery.Source: §D.4.3 · pp. 45–46

D.4.4 Radiology

Ultrasound shows a benign-appearing, discrete retroareolar mass, making juvenile fibroadenoma the leading hypothesis while gynecomastia remains possible. Pending laboratory results guide targeted imaging and follow-up.

D.4.4 Radiology

  • The differential contrasts juvenile fibroadenoma’s discrete nodule with gynecomastia’s typically fan-shaped tissue, while rare tumor-related hormone sources and carcinoma remain considerations.The proposed initial approach is conservative observation, with biopsy prompted by suspicious imaging changes.Source: §D.4.4 · p. 46
  • Scrotal ultrasound is the next essential imaging step; adrenal imaging is considered if pending laboratory values suggest an adrenal source of estrogen excess.If targeted imaging and laboratory results are negative, follow-up breast ultrasound in 3 to 6 months is appropriate.Source: §D.4.4 · pp. 46–47
  • Juvenile fibroadenoma is the leading hypothesis because the mass is discrete and nodular with classic benign solid-lesion features, although unilateral gynecomastia remains possible.The pending laboratory values and chest-imaging report remain important gaps in narrowing the differential.Source: §D.4.4 · pp. 46–47
  • Ultrasound shows a well-circumscribed, oval, hypoechoic, hypovascular retroareolar mass with smooth margins and parallel orientation, without malignant features.The left breast shows a normal bud; early adrenarche is present alongside prepubertal testes and phallus and age-concordant bone age.Source: §D.4.4 · pp. 46–47

D.5.1 Final Opinion

The final opinion favors a benign localized breast process with premature adrenarche, while noting uncertainty about the next diagnostic step. The accompanying assessment instructions score reports across separate components and criteria, with explicit rules for factual errors and clinical risk.

D.5.1 Final Opinion

  • The 8-year-old’s persistent, enlarging breast mass is considered most consistent with a benign localized process and premature adrenarche; central precocious puberty is excluded.Pending laboratory and chest-imaging results remain critical data gaps, and specialists disagree between observation and biopsy.Source: §D.5.1 · p. 47

Final Differential Diagnosis

  • The differential prioritizes prepubertal gynecomastia and a benign fibroepithelial lesion, while retaining hormone-secreting tumors and malignancy as alternatives.Source: Final Differential Diagnosis · p. 47

Final Diagnostic Plan

  • The diagnostic plan calls for review of pending hormone and chest-imaging results, scrotal ultrasound, and either follow-up breast ultrasound or biopsy.Source: Final Diagnostic Plan · p. 47

Final Management Plan

  • Management depends on findings: treat an identified hormone-secreting tumor, observe or biopsy if initial tests are normal, and refer malignancy for pediatric oncology planning.Source: Final Management Plan · p. 47

Safety Warnings

  • Benign ultrasound appearance does not rule out rare malignancy or hormonally active tumors, and persistence with enlargement may warrant tissue diagnosis.Scrotal ultrasound and laboratory evaluation are required before attributing the mass solely to gynecomastia.Source: Safety Warnings · p. 47

Structure of the spreadsheet assessment

General 0–3 scoring scale

  • Scores range from 0 for major, unsafe, or fabricated errors to 3 for accurate, clear, and specific work; uncertainty between scores favors the lower score when patient risk or management could be affected.Clinically significant fabricated facts can force a zero for factual accuracy and cap related reasoning or safety criteria at one.Source: General 0–3 scoring scale · p. 49, Rule for fabricated facts · p. 49

Factual accuracy and sources

Completeness and relevance of the data used

The assessment evaluates whether reports use relevant data, reason coherently, consider alternatives, and provide justified, safe conclusions and plans. It also distinguishes report quality from case complexity and requires specific comments and final spreadsheet checks.

Completeness and relevance of the data used

Coherence of clinical reasoning

Quality of differential diagnosis

Quality of the final clinical conclusion

Justification and specificity of management strategy

Clinical safety

  • Clinical-safety scoring checks whether the report creates patient risk or omits threats requiring immediate monitoring or action.Source: Clinical safety · p. 52

Whole-case criteria

Writing comments

Related papers

Loading 2610.22298v1…